Evidence map›Paper›PMID 27782111›Full record

ArticleMucosal immunology2017

Inflammatory cues enhance TGFβ activation by distinct subsets of human intestinal dendritic cells via integrin αvβ8.

T M Fenton, A Kelly, E E Shuttleworth, C Smedley, A Atakilit, F Powrie, S Campbell, S L Nishimura, D Sheppard, S Levison and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Mucosal immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 63 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Dendritic cells in food allergy, treatment, and tolerance.The Journal of allergy and clinical immunology · 2024
    Review
  6. Article
  7. Adipose tissue depot specific expression and regulation of fibrosis-related genes and proteins in experimental obesity.Mammalian genome : official journal of the International Mammalian Genome Society · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. TGFβ biology in cancer progression and immunotherapy.Nature reviews. Clinical oncology · 2021
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 3 countries.

T M FentonManchester Collaborative Centre for Inflammation Research, University of Manchester, Manchester, UK.
A KellyManchester Collaborative Centre for Inflammation Research, University of Manchester, Manchester, UK.
E E ShuttleworthManchester Collaborative Centre for Inflammation Research, University of Manchester, Manchester, UK.
C SmedleyManchester Collaborative Centre for Inflammation Research, University of Manchester, Manchester, UK.
A AtakilitLung Biology Center, Department of Medicine, University of California, San Francisco, CA, USA.
F PowrieKennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
S CampbellGastroenterology Unit, Manchester Royal Infirmary, Central Manchester University Hospital NHS Foundation Trust, Manchester, UK.
S L NishimuraDepartment of Pathology, University of California, San Francisco, CA, USA.
D SheppardLung Biology Center, Department of Medicine, University of California, San Francisco, CA, USA.
S LevisonGastroenterology Unit, Manchester Royal Infirmary, Central Manchester University Hospital NHS Foundation Trust, Manchester, UK.
J J WorthingtonManchester Immunology Group, Faculty of Life Sciences, University of Manchester, Manchester, UK.
M J LehtinenDuPont Nutrition & Health, Global Health and Nutrition Science, Kantvik, Finland.
M A TravisManchester Collaborative Centre for Inflammation Research, University of Manchester, Manchester, UK.
Centre for Inflammation Research · GBUniversity of California, San Francisco · USUniversity of Manchester · GBDuPont (Finland) · FILancaster University · GBManchester Royal Infirmary · GBNuffield Orthopaedic Centre · GB

Funding

Role of genetic variation in TGF-beta overactivation in COPDR01HL113032 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NISHIMURA, STEPHEN L · 2012 to 2015
$2.1M
Biotechnology and Biological Sciences Research Council BB/G001103/1Medical Research Council MR/L011840/1Medical Research Council MR/M00242X/1NHLBI NIH HHS R01 HL113032Wellcome TrustWellcome Trust 088785/Z/09/ZWellcome Trust 097820/Z/11/B
6 · The paper itself

Abstract

Regulation of intestinal T-cell responses is crucial for immune homeostasis and prevention of inflammatory bowel disease (IBD). A vital cytokine in regulating intestinal T cells is transforming growth factor-β (TGFβ), which is secreted by cells as a latent complex that requires activation to function. However, how TGFβ activation is regulated in the human intestine, and how such pathways are altered in IBD is completely unknown. Here we show that a key activator of TGFβ, integrin αvβ8, is highly expressed on human intestinal dendritic cells (DCs), specifically on the CD1c

Indexed as

AdultAgedAntigens, CD1CD4-Positive T-LymphocytesCells, CulturedDendritic CellsFemaleForkhead Transcription FactorsGlycoproteinsHumansInflammatory Bowel DiseasesIntegrinsIntestinesLipopolysaccharidesMaleMiddle AgedAntigens, CD1CD1C protein, humanForkhead Transcription FactorsFOXP3 protein, humanGlycoproteinsintegrin alphavbeta8IntegrinsLipopolysaccharidesTLR4 protein, humanToll-Like Receptor 4Transforming Growth Factor beta

Identifiers

PMID27782111
PMCPMC5439516
OpenAlexW2541536818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.